ESMO 2024: Optimising the personalisation of prostate cancer treatment
Dr Albiges talks to ecancertv at ASCO GU 2015 about the surprising impact of BMI on kidney cancer.
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC
EAU 2024: Bladder cancer latest
Adjuvant radiotherapy has no benefit following radical prostatectomy
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 11th - 17th, 2023
Latest in immunological technologies that can treat, control, and prevent cancer
OncoAlert Round Up for August 4th - 10th, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer